Seema Nagpal
Academic Appointments
- Clinical Assistant Professor, Neurology & Neurological Sciences
Key Documents
Contact Information
-
Clinical Offices
Adult Neuro-Oncology Program 875 Blake Wilbur Dr CC2221 Stanford, CA 94305 Tel Work (650) 725-8630 Fax (650) 498-4686
- Academic Offices
Personal Information Email Tel (650) 725-6563 Tel (650) 725-8630Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Neuro Oncology
- Neurology
- Glioma
- glioblastoma
- Brain Metastasis
- Carcinomatosis, Leptomeningeal
Professional Education
| Residency: | University of California, School of Medicine CA (2009) |
| Fellowship: | Stanford University CA (2011) |
| Board Certification: | Neurology, American Board of Psychiatry and Neurology (2010) |
| Internship: | University of California, School of Medicine CA (2007) |
| Residency: | University Of Iowa Hospitals & Clinics IA (2005) |
| Medical Education: | University of Pennsylvania School of Medicine PA (2004) |
Scientific Focus
Current Research Interests
Glioblastoma is an aggressive brain cancer with limited options for therapy. Currently, our group is looking to bring at least 2 new trials for treatment at the time of diagnosis and at recurrence to Stanford.
The spread of systemic cancer, like lung and breast cancers, to the covering of the brain, is adevastating and often lethal complication. I am working to bring a trials for early detection and treatment to Stanford, with the and making this a unique focus of our new brain tumor center.
Clinical Trials
- Recruiting Molecular Analysis of Thoracic Malignancies
- Recruiting Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level
- Not Recruiting A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
- Recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
- Not Recruiting A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Patients With Recurrent Glioblastoma
Publications
- A case series of NSCLC patients with different molecular characteristics and choroidal metastases: improvement in vision with treatment including pemetrexed and bevacizumab. J Thorac Oncol. 2013; (2): e17-8
- A patient with anaplastic lymphoma kinase-positive non-small cell lung cancer with development of leptomeningeal carcinomatosis while on targeted treatment with crizotinib. J Natl Compr Canc Netw. 2013; (4): 389-94
- Advances in the management of glioblastoma: the role of temozolomide and MGMT testing. Clin Pharmacol. 2013: 1-9
- Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab. 2013; (5): 732-43
- The incidence and significance of multiple lesions in glioblastoma. J Neurooncol. 2013; (1): 91-7
- Neoplastic myelopathy. Semin Neurol. 2012; (2): 137-45
Help
Trial Administration